Patent intelligence · US
US 2006127471
Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy
Patent details — US 2006127471
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 15, 2006
- Expiration
- Jun 10, 2026
- Applicant
- CERAMOPTEC IND INC [DE]
- CPC classes
- A61K 9/ 127 A I, A61K 31/ 407 A I, A61K 31/ 555 A I, A61K 41/ 00 A I
Quick answer
US 2006127471 (Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy) is held by CERAMOPTEC IND INC [DE]. Status: granted. Granted Jun 15, 2006. Expires Jun 10, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CERAMOPTEC IND INC [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 127 A I, A61K 31/ 407 A I, A61K 31/ 555 A I, A61K 41/ 00 A I, A61K/31407, A61K/31555
More from CERAMOPTEC IND INC [DE]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
granted -
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
granted
Frequently asked questions
What is US patent 2006127471?
US 2006127471 (Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy) is held by CERAMOPTEC IND INC [DE]. Status: granted. Granted Jun 15, 2006. Expires Jun 10, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2006127471?
CERAMOPTEC IND INC [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2006127471 expire?
Our index shows an expiration date of Jun 10, 2026 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.